Frymoyer A, Vasconcelos AG, Juul SE, Comstock BA, et al. On target dosing: erythropoietin exposure in neonates with hypoxic-ischemic encephalopathy in the HEAL trial. Pediatr Res 2024 Nov 10. doi: 10.1038/s41390-024-03709.
PMID: 39523391